| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Interim CEO And CFO
1 company
David Matthew T is a Chief Financial Officer at CorMedix Inc.. Recent SEC Form 4 filings include 4 buys and 0 sells.
Estimated insider holdings value: $840K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 6, 2021 | CRMD Cormedix Inc. | Interim CEO And CFO | Buy | 1,000 | $4.50 | $4,500.00 | +46.5% | -5.8% | -14.5% | |
| Dec 6, 2021 | CRMD Cormedix Inc. | Interim CEO And CFO | Buy | 1,000 | $4.50 | $4,500.00 | +46.5% | -5.8% | -14.5% | |
| Nov 17, 2021 | CRMD Cormedix Inc. | Interim CEO And CFO | Buy | 1,000 | $5.07 | $5,070.00 | +87.0% | -18.7% | -21.5% | |
| Sep 3, 2020 | CRMD Cormedix Inc. | Chief Financial Officer | Buy | 1,150 | $4.07 | $4,680.50 | New | - | - |